The Food and Drug Administration is expanding its recall of widely prescribed blood pressure medicines due to contamination with a cancer-related chemical.
Monday's announcement addressed an additional five batches of the generic losartan drug made by Torrent Pharmaceuticals Limited. The lots include losartan potassium tablets and losartan potassium / hydrochlorothiazide tablets.
The batches downloaded contain traces of N-methylnitrosobutyric acid or NMBA, which is linked to cancer.
Angiotensin II Receptor Update (ARB) Recalls: Torrent is expanding its voluntary recall of losartan to include additional batches: https://t.co/4Tl2ti0tP4. pic.twitter.com/4ZrOjIvtQk
̵1; FDA Drug Information (@FDA_Drug_Info) September 20, 2019
This is the fifth time in 2019 that Torrent Pharmaceuticals is expanding its voluntary recall of losartan. The withdrawal was announced for the first time in January.
Losartan is a generic blocker of angiotensin II receptor or ARB and is used to treat high blood pressure as well as heart failure. In the last year, dozens of batches of generic ARB have been withdrawn from the market due to the presence of chemical contaminants called nitrosamines, which are associated with an increased risk of some cancers.